Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.
about
Incretin physiology and pathophysiology from an Asian perspectivePhysiology of proglucagon peptides: role of glucagon and GLP-1 in health and diseasePeripheral signals mediate the beneficial effects of gastric surgery in obesityLipotoxicity disrupts incretin-regulated human β cell connectivityMechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes.Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.Pancreatic β-cell proliferation in obesity.Plasma gastric inhibitory polypeptide and glucagon-like peptide-1 levels after glucose loading are associated with different factors in Japanese subjects.Effects of glucose and meal ingestion on incretin secretion in Japanese subjects with normal glucose toleranceIngestion of a moderate high-sucrose diet results in glucose intolerance with reduced liver glucokinase activity and impaired glucagon-like peptide-1 secretionLittle enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls.Obesity may attenuate the HbA1c-lowering effect of sitagliptin in Japanese type 2 diabetic patients.The Glucose-lowering Efficacy of Sitagliptin in Obese Japanese Patients with Type 2 Diabetes.Islet cell antibody-positive versus -negative phenotypic type 2 diabetes in youth: does the oral glucose tolerance test distinguish between the two?Inadequate Triglyceride Management Worsens the Durability of Dipeptidyl Peptidase-4 Inhibitor in Subjects with Type 2 Diabetes MellitusEffects of exenatide in a morbidly obese patient with type 2 diabetesIs the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes.Effects of high-fat diet and the anti-diabetic drug metformin on circulating GLP-1 and the relative number of intestinal L-cells.Recent advances in clinical practice challenges and opportunities in the management of obesity.β-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes.Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes.Incretin response in Asian type 2 diabetes: Are Indians different?Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies.Efficacy and safety of sitagliptin in Japanese patients with type 2 diabetesEffect of weight loss on adipokine levels in obese patients.β-Cell Sensitivity to GLP-1 in Healthy Humans Is Variable and Proportional to Insulin Sensitivity.Physiology of incretins in health and disease.The role of incretin therapy at different stages of diabetes.Adaptation of β-Cell and Endothelial Function to Carbohydrate Loading: Influence of Insulin ResistanceIncretin Effect in Women with Former Gestational Diabetes within a Short Period after Delivery.Rye-Based Evening Meals Favorably Affected Glucose Regulation and Appetite Variables at the Following Breakfast; A Randomized Controlled Study in Healthy Subjects.Is endogenous GLP-1 the only important enhancer of glucose-induced insulin secretion in type 2 diabetes?The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes.Insulin combined with Chinese medicine improves glycemic outcome through multiple pathways in patients with type 2 diabetes mellitus.Effect of glycemia on plasma incretins and the incretin effect during oral glucose tolerance test.Effect of the low- versus high-intensity exercise training on endoplasmic reticulum stress and GLP-1 in adolescents with type 2 diabetes mellitusLong chain saturated and unsaturated fatty acids exert opposing effects on viability and function of GLP-1-producing cells: Mechanisms of lipotoxicity.Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease.
P2860
Q26784623-21887E04-3760-4CFE-9B68-63B9EACF9721Q27027920-C310A3B2-8896-4EFC-9DE3-59C61B01AC44Q28088425-2C45521B-0EBA-46C1-93D1-5B474DF4CB3DQ30634760-0AE412C6-F168-4ECA-9588-A38A779E51FEQ31137356-96C00636-5354-4755-864F-799B9BC93F99Q33569425-74B206D6-8C07-463C-8D6D-CF7B19AD203DQ33578671-F49CD461-5326-422E-80CA-AB34CA0CE67DQ33585620-432636F3-7862-40A2-BF06-D4314EE5A5D5Q33585692-7881913B-C6BB-49ED-908A-807904FB0ABBQ33603296-7502EC15-EED8-441D-B8F5-29F6949BB522Q33609513-AEDAC0C8-7B41-4351-B8CF-5F5E30429A57Q33609811-7050087F-E5B5-4C2D-B0BA-69AC835E5477Q33619167-8D96CD4A-1C9A-48B3-B380-400BC277CC82Q33683775-0E09D737-7851-4033-91B6-292193C02A21Q33775600-0182E04E-DA74-4611-B2D3-C69431F572B9Q33785151-46AB33E7-EBF5-4A31-86C0-71B6B1AA3861Q33803409-15C9C9CD-36D6-4745-BF64-6A3AC906E61BQ33869732-0FAFBE97-5096-4755-A507-0BE8709D7C6DQ33898060-5D143503-033C-4371-BE75-349DC7DEE45EQ34219768-58D61494-AD67-4597-8BBD-238C2278FAFFQ34393402-5047A77E-919F-4A93-9DD4-16D973AD478BQ34503601-54F2DC94-C815-4015-86BA-631EFB46C4DDQ34620636-A5245D0F-6BFF-4FB9-A1E5-5C1313E19B27Q34878323-99E8CAE0-EA69-42D2-9137-113E7F948A8AQ34996877-720EC997-D932-4314-888D-359451B8EF32Q35087917-FB17C0A5-FAB9-4E0C-8109-9A86ABDFB3B8Q35178805-E5E91BAA-4745-4BCE-B3D0-219E36D9689CQ35680897-B23ABA38-F06A-4696-84D7-0B8D95A71A2EQ35760279-2B0A5CE0-10CB-4AE3-B46F-9D6615351163Q35760288-2D1C697A-46DE-422F-B9DF-68C18110361FQ35769553-CBDC0B2C-1C07-45BD-8A82-7E336BA95C19Q35936659-1663D4B4-118E-4A79-AC31-082FA1C26294Q35962385-1446D249-C32D-46FD-A4E2-8D87AA79DE11Q36182510-7590B586-3D88-4971-9F05-DF74E9CBD894Q36182540-0E0C2A0A-DA6A-4845-ACF0-471E3B93868FQ36232791-ADF5D489-05D3-4D38-AEE8-54A9B6D7D07DQ36339659-325E8AAD-FCE6-40CF-B158-F0E12F3F80E9Q36342594-69F9B6DA-A6D3-4D9F-AEAD-651C5B9056C5Q36375667-CC487586-18CD-4A73-9AE1-0CD065A790D4Q36503839-576F4884-1D0A-4842-9C2B-2BF27C131E0C
P2860
Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Separate impact of obesity and ...... and type 2 diabetic patients.
@en
Separate impact of obesity and ...... and type 2 diabetic patients.
@nl
type
label
Separate impact of obesity and ...... and type 2 diabetic patients.
@en
Separate impact of obesity and ...... and type 2 diabetic patients.
@nl
prefLabel
Separate impact of obesity and ...... and type 2 diabetic patients.
@en
Separate impact of obesity and ...... and type 2 diabetic patients.
@nl
P2093
P50
P921
P356
P1433
P1476
Separate impact of obesity and ...... and type 2 diabetic patients.
@en
P2093
Andrea Mari
Arturo Casolaro
Ele Ferrannini
P304
P356
10.2337/DB07-1315
P407
P577
2007-12-27T00:00:00Z